Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease
Abstract Conventional disease animal models have limitations on the conformity to the actual clinical situation. Disease-syndrome combination (DS) modeling may provide a more efficient strategy for biomedicine research. Disease model and DS model of renal fibrosis in chronic kidney disease were esta...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/40756b0c090a4c42b1a589c4caaaa939 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:40756b0c090a4c42b1a589c4caaaa939 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:40756b0c090a4c42b1a589c4caaaa9392021-12-02T15:06:12ZDisease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease10.1038/s41598-017-09311-02045-2322https://doaj.org/article/40756b0c090a4c42b1a589c4caaaa9392017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-09311-0https://doaj.org/toc/2045-2322Abstract Conventional disease animal models have limitations on the conformity to the actual clinical situation. Disease-syndrome combination (DS) modeling may provide a more efficient strategy for biomedicine research. Disease model and DS model of renal fibrosis in chronic kidney disease were established by ligating the left ureter and by ligating unilateral ureteral combined with exhaustive swimming, respectively. Serum metabolomics was conducted to evaluate disease model and DS model by using ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Potential endogenous biomarkers were identified by multivariate statistical analysis. There are no differences between two models regarding their clinical biochemistry and kidney histopathology, while metabolomics highlights their difference. It is found that abnormal sphingolipid metabolism is a common characteristic of both models, while arachidonic acid metabolism, linolenic acid metabolism and glycerophospholipid metabolism are highlighted in DS model. Metabolomics is a promising approach to evaluate experiment animal models. DS model are comparatively in more coincidence with clinical settings, and is superior to single disease model for the biomedicine research.Shasha LiPeng XuLing HanWei MaoYiming WangGuoan LuoNizhi YangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Shasha Li Peng Xu Ling Han Wei Mao Yiming Wang Guoan Luo Nizhi Yang Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease |
description |
Abstract Conventional disease animal models have limitations on the conformity to the actual clinical situation. Disease-syndrome combination (DS) modeling may provide a more efficient strategy for biomedicine research. Disease model and DS model of renal fibrosis in chronic kidney disease were established by ligating the left ureter and by ligating unilateral ureteral combined with exhaustive swimming, respectively. Serum metabolomics was conducted to evaluate disease model and DS model by using ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Potential endogenous biomarkers were identified by multivariate statistical analysis. There are no differences between two models regarding their clinical biochemistry and kidney histopathology, while metabolomics highlights their difference. It is found that abnormal sphingolipid metabolism is a common characteristic of both models, while arachidonic acid metabolism, linolenic acid metabolism and glycerophospholipid metabolism are highlighted in DS model. Metabolomics is a promising approach to evaluate experiment animal models. DS model are comparatively in more coincidence with clinical settings, and is superior to single disease model for the biomedicine research. |
format |
article |
author |
Shasha Li Peng Xu Ling Han Wei Mao Yiming Wang Guoan Luo Nizhi Yang |
author_facet |
Shasha Li Peng Xu Ling Han Wei Mao Yiming Wang Guoan Luo Nizhi Yang |
author_sort |
Shasha Li |
title |
Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease |
title_short |
Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease |
title_full |
Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease |
title_fullStr |
Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease |
title_full_unstemmed |
Disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease |
title_sort |
disease-syndrome combination modeling: metabolomic strategy for the pathogenesis of chronic kidney disease |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/40756b0c090a4c42b1a589c4caaaa939 |
work_keys_str_mv |
AT shashali diseasesyndromecombinationmodelingmetabolomicstrategyforthepathogenesisofchronickidneydisease AT pengxu diseasesyndromecombinationmodelingmetabolomicstrategyforthepathogenesisofchronickidneydisease AT linghan diseasesyndromecombinationmodelingmetabolomicstrategyforthepathogenesisofchronickidneydisease AT weimao diseasesyndromecombinationmodelingmetabolomicstrategyforthepathogenesisofchronickidneydisease AT yimingwang diseasesyndromecombinationmodelingmetabolomicstrategyforthepathogenesisofchronickidneydisease AT guoanluo diseasesyndromecombinationmodelingmetabolomicstrategyforthepathogenesisofchronickidneydisease AT nizhiyang diseasesyndromecombinationmodelingmetabolomicstrategyforthepathogenesisofchronickidneydisease |
_version_ |
1718388577075724288 |